Distillery

BioCentury’s Distillery, a curated collection of top translational studies in the scientific literature, provides brief summaries of preclinical papers that showcase targets and technologies with disease-modifying effects.

The summaries distill each paper down to its most translationally relevant experiments and conclusions, and include information on the innovation’s patent and licensing status when available, along with author and bibliographic information.

The Distillery enriches for licensing opportunities, meaning studies from academic labs are prioritized over those from companies more likely to develop programs themselves. It emphasizes original applications of targets and compounds – those already in the clinic are not included unless the use case is novel.

Available to subscribers only. Request a trial to explore Distillery.

Why Distillery?

BioCentury’s editorial team selects 20-40 papers per month from a survey of over 25 journals, prioritizing studies that identify new target opportunities or propose new technologies for established targets.

• Search for key innovations in any area and identify the investigators behind the work
• Find licensing and partnering opportunities for your portfolios
• Build networks in specific geographies, disease areas or target spaces
• Map competitive landscapes and spot trends

Available to subscribers only. Request a trial to explore Distillery.